Hip Osteonecrosis Is Associated with Increased Plasma IL-33 Level

Area of Science:

• Immunology
• Orthopedics
• Cytokine Research

Background:

• Interleukin-33 (IL-33), an IL-1 family cytokine, is released from osteonecrotic bone.
• Osteonecrosis of the femoral head (ONFH) is a debilitating condition requiring further understanding of its pathogenesis.

Purpose of the Study:

• To investigate the potential role of IL-33 in the development and progression of ONFH.
• To compare plasma IL-33 levels in ONFH patients versus healthy controls.
• To analyze IL-33 levels in relation to ONFH staging and etiology.

Main Methods:

• Prospective study involving 40 ONFH patients and 40 matched healthy controls.
• Plasma IL-33 levels were quantified using a commercially available ELISA kit.
• IL-33 levels were analyzed across different ARCO stages, CJFH types, and etiologies.

Main Results:

• Plasma IL-33 levels were significantly higher in ONFH patients compared to controls.
• IL-33 levels did not vary significantly across different ARCO stages.
• Higher IL-33 levels were observed in patients with CJFH type L3 compared to L1 and L2; no significant differences were found based on ONFH etiology (steroid, alcohol, idiopathic).

Conclusions:

• Elevated IL-33 levels in ONFH patients suggest a potentially detrimental role in the disease.
• IL-33 may be associated with the prognosis of ONFH.
• IL-33 warrants further investigation for its specific involvement in ONFH pathogenesis.